Palisade Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.02M | Sell |
1,099,759
-41,830
| -4% | -$267K | 0.2% | 134 |
|
|
2025
Q1 | $5.55M | Buy |
1,141,589
+202,857
| +22% | +$986K | 0.16% | 155 |
|
|
2024
Q4 | $8.97M | Buy |
938,732
+188,802
| +25% | +$1.8M | 0.24% | 116 |
|
|
2024
Q3 | $6.26M | Buy |
749,930
+296,101
| +65% | +$2.47M | 0.17% | 145 |
|
|
2024
Q2 | $3.1M | Sell |
453,829
-7,819
| -2% | -$53.3K | 0.08% | 205 |
|
|
2024
Q1 | $1.17M | Buy |
461,648
+11,236
| +2% | +$28.4K | 0.03% | 279 |
|
|
2023
Q4 | $1.08M | Sell |
450,412
-58,913
| -12% | -$141K | 0.03% | 298 |
|
|
2023
Q3 | $1.73M | Sell |
509,325
-29,093
| -5% | -$98.9K | 0.05% | 245 |
|
|
2023
Q2 | $3.96M | Buy |
538,418
+24,547
| +5% | +$180K | 0.11% | 185 |
|
|
2023
Q1 | $5.32M | Buy |
513,871
+12,199
| +2% | +$126K | 0.14% | 166 |
|
|
2022
Q4 | $5.92M | Sell |
501,672
-25,317
| -5% | -$299K | 0.16% | 166 |
|
|
2022
Q3 | $11.1M | Sell |
526,989
-39,091
| -7% | -$820K | 0.31% | 105 |
|
|
2022
Q2 | $17.6M | Buy |
566,080
+5,671
| +1% | +$176K | 0.48% | 71 |
|
|
2022
Q1 | $23M | Sell |
560,409
-24,548
| -4% | -$1.01M | 0.53% | 66 |
|
|
2021
Q4 | $25.4M | Sell |
584,957
-58,507
| -9% | -$2.54M | 0.51% | 69 |
|
|
2021
Q3 | $32.2M | Buy |
643,464
+40,984
| +7% | +$2.05M | 0.7% | 42 |
|
|
2021
Q2 | $38M | Sell |
602,480
-23,489
| -4% | -$1.48M | 0.86% | 25 |
|
|
2021
Q1 | $58.2M | Buy |
625,969
+46,960
| +8% | +$4.36M | 1.37% | 5 |
|
|
2020
Q4 | $51.9M | Buy |
579,009
+150,134
| +35% | +$13.5M | 1.33% | 5 |
|
|
2020
Q3 | $44.3M | Buy |
428,875
+58,825
| +16% | +$6.08M | 1.31% | 5 |
|
|
2020
Q2 | $29.3M | Buy |
370,050
+169,448
| +84% | +$13.4M | 0.93% | 14 |
|
|
2020
Q1 | $11.6M | Buy |
200,602
+75,686
| +61% | +$4.38M | 0.41% | 78 |
|
|
2019
Q4 | $6.74M | Buy |
+124,916
| New | +$6.74M | 0.19% | 151 |
|
|
2016
Q3 | – | Sell |
-7,155
| Closed | -$201K | – | 568 |
|
|
2016
Q2 | $201K | Buy |
+7,155
| New | +$201K | 0.01% | 518 |
|